Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults
- PMID: 24892249
- DOI: 10.1016/j.vaccine.2014.05.033
Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults
Comment on
-
Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.Vaccine. 2013 Aug 20;31(37):4024-32. doi: 10.1016/j.vaccine.2013.05.014. Epub 2013 May 22. Vaccine. 2013. PMID: 23707166
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
